T1	Participants 115 128	GERD patients
T2	Participants 215 263	gastro-esophageal reflux disease (GERD) patients
T3	Participants 506 531	Forty-seven GERD patients
T4	Participants 610 629	29 healthy controls
T5	Participants 1973 1977	GERD
